Recombinant immunotoxin and use in treating tumors
CA 2508519 A1 · Owner: Onda, Masanori · Inventors: Pastan, Ira; Cheung, Nai-Kong; Onda, Masanori
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Immunotoxins are disclosed that include a toxin a variable region of a heavy , chain of a monoclonal antibody that binds the antigen specifically bound by monoclonal antibody 8H9, and a variable region of a light chain of the monoclonal antibody that binds the antigen specifically bound by monoclonal antibody 8H9 and effector molecule. These immunotoxins include scFv and dsFv of monoclonal antibody 8H9. The immunotoxins are of use for the treatment of tumors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 1, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 1, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 1, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.